Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 · New England Journal of Medicine · 2,543 citations
https://doi.org/10.1056/nejmoa1501352
P
Paul W. Armstrong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.3K
Papers
82.2K
Citations
118
h-index
653
i10-index
Paul W. Armstrong is an academic researcher from University of Alberta. The author has contributed to research in topics: Acute Myocardial Infarction Research & Cardiac Imaging and Diagnostics & Heart Failure Treatment and Management. The author has an h-index of 118, co-authored 1093 publications.
ORCID: 0000-0002-0460-3445Papers by this author
worksFibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction
2013 · New England Journal of Medicine · 765 citations
https://doi.org/10.1056/nejmoa1301092
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
2011 · New England Journal of Medicine · 751 citations
https://doi.org/10.1056/nejmoa1109719
Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome
2007 · Circulation · 371 citations
https://doi.org/10.1161/circulationaha.106.650846
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
2015 · American Heart Journal · 73 citations
https://doi.org/10.1016/j.ahj.2015.04.006
Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality
2014 · Circulation Heart Failure · 57 citations
https://doi.org/10.1161/circheartfailure.113.000872
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat